Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 2
Abstract
Quality control (QC) applications are important for the reliability and accuracy of the results obtained from positron emission tomography (PET) imaging systems in clinical trials. With these applications, exposure of patients and employees to more radiation will be prevented, and it will be possible to detect the systems that lost their performance compared to their installation time. QC applications are grouped as acceptance and reference tests, routine periodic QC tests. PET performance tests standardized by National Electrical Manufacturers Association (NEMA) should be used as acceptance and reference tests. In addition, the performance of the device should be monitored by following these tests at six-month intervals. PET/computerized tomography (CT) manufacturers often recommend routine QC procedures for their equipment and require users to follow these recommendations to a minimum. If standards are not defined for routine QC procedures, it is recommended to comply with the general minimum standards for routine QC that all PET/CT centers must perform. Routine QC protocols, the image quality of the PET system; CT image quality and CT dose of the patient; the accuracy of CT-based attenuation corrections; the accuracy of the CT and PET co-registration should ensure that problems that can interact any of the performance characteristics are identified. Since performing PET/CT scans by equipment that does not comply with their specifications may compromise image quality, interpretation of images and reliability of results, daily QC parameters must be evaluated and necessary corrective procedures must be taken prior to scanning. The tests are carried out using the protocol provided by the manufacturer.
Authors and Affiliations
Tuğba Hacıosmanoğlu, Mustafa Demir, Türkay Toklu, F. Suna Kıraç, Mehmet İnce, Yasemin Parlak, Bilal Kovan, Semra Dönmez, Aslı Ayan, İnci Alıç Özaslan, Meral Hiçürkmez, Nami Yeyin, Leyla Poyraz ve TNTD Kalite kontrol ve Radyasyon Güvenliği çalışma grubu üyeleri
Keywords
Related Articles
- EP ID EP688741
- DOI 10.4274/nts.galenos.2020.0008
- Views 187
- Downloads 0
Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma
Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...
Iodine-123 Meta-iodobenzylguanidine Cardiac Innervation Imaging Guideline
Sympathetic innervation of the heart plays an important role in the pathophysiology of diseases, especially congestive heart failure and arrhythmias. Iodine-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy allows fo...
Differentiated Thyroid Carcinoma in Pediatric Age Group/Differences in Diagnosis, Therapy and Follow-up
Differentiated thyroid cancer in childhood is rare. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable...
Renal Toxicity After Radionuclide Therapy
With the introduction of radionuclide therapies, the probability of toxicity has increased in critical organs such as kidney and bone marrow. Although these toxicity rates are relatively low in targeted therapies such as...
Guideline for Dopaminergic Imaging in Parkinsonian Syndromes
The purpose of this guideline, which is prepared by the neuropsychiatry imaging task group of the Turkey Association of Nuclear Medicine, is to help nuclear medicine physicians in their practice of dopaminergic imaging i...